Document Detail


Ultrasound-guided injection of ectopic pregnancy.
MedLine Citation:
PMID:  10073298     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Preliminary studies have demonstrated that salpingocentesis is a safe and effective treatment for unruptured ectopic pregnancies that are visible by transvaginal ultrasound. So far, experience with this technique has been confined to only a few centers around the world. The most promising results of these studies has been the virtual absence of side effects associated with local injection of either methotrexate or hyperosmolar glucose. Large prospective trials comparing efficacy, safety, and overall cost of salpingocentesis against systemic methotrexate will be necessary to better define the role of salpingocentesis in the management of ectopic pregnancy. Patient recruitment for this type of clinical trial would be feasible and acceptable to patients because both treatment arms would avoid surgery.
Authors:
J G Natofsky; J Lense; J C Mayer; T R Yeko
Related Documents :
23162358 - Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindl...
12423828 - Triplet cervical pregnancy treated with intraamniotic methotrexate.
686528 - Cholecystectomy during pregnancy.
1534728 - Methotrexate for treatment of unruptured ectopic pregnancy.
19468738 - Nomogram of amniotic fluid volume at 7 to 10+6 weeks of pregnancy by three-dimensional ...
887128 - Fetal loss, twinning and birth weight after oral-contraceptive use.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical obstetrics and gynecology     Volume:  42     ISSN:  0009-9201     ISO Abbreviation:  Clin Obstet Gynecol     Publication Date:  1999 Mar 
Date Detail:
Created Date:  1999-04-29     Completed Date:  1999-04-29     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0070014     Medline TA:  Clin Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  39-47; quiz 55-6     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa 33606, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Folic Acid Antagonists / administration & dosage,  therapeutic use
Humans
Injections
Methotrexate / administration & dosage,  therapeutic use
Pregnancy
Pregnancy, Ectopic / drug therapy*
Treatment Outcome
Ultrasonics
Chemical
Reg. No./Substance:
0/Folic Acid Antagonists; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surgical management of ectopic pregnancy.
Next Document:  Diagnosis of perinatal TORCH infections.